AdvisorShares Psychedelics ETF Review and Aggregate Rating (PSIL) $PSIL

robot
Abstract generation in progress

The AdvisorShares Psychedelics ETF (PSIL) currently holds an aggregate “Moderate Buy” rating with a consensus price target of $16.47, based on 179 analyst ratings covering 19 portfolio companies. The ETF’s holdings show a mix of ratings, with the largest weighting in Atai Beckley and Definium Therapeutics. This analysis provides an overview of how MarketBeat aggregates ETF ratings and lists detailed ratings and potential upsides for the top holdings within the PSIL ETF.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin